论文部分内容阅读
目的观察氯吡咯雷与阿托伐他汀联合应用治疗急性冠脉综合征(Acute Coronary Syndromo,ACS)的效果和安全性。方法 72例ACS患者随机分为氯吡咯雷与阿托伐他汀联合应用治疗组36例和对照组36例。对照组应用常规措施治疗,治疗组在应用常规措施治疗的基础上加服氯吡咯雷与阿托伐他汀,1个月后观察两组对ACS的治疗效果及不良反应。结果治疗组总有效率高于对照组,不良反应两组无差异。结论氯吡咯雷与阿托伐他汀联合应用治疗急性冠脉综合征的疗效确切,是治疗ACS的有效方法之一。
Objective To investigate the efficacy and safety of combination of clopidogrel and atorvastatin in the treatment of acute coronary syndrome (Acute Coronary Syndrome). Methods Seventy-two ACS patients were randomly divided into clopidogrel and atorvastatin combined treatment group 36 cases and control group 36 cases. The control group was treated with routine measures. The treatment group was given clopidogrel and atorvastatin on the basis of conventional measures. After 1 month, the curative effect and adverse reactions of both groups were observed. Results The total effective rate of the treatment group was higher than that of the control group, with no difference between the two groups. Conclusion The combination of clopidogrel and atorvastatin is effective in the treatment of acute coronary syndrome and is one of the effective ways to treat ACS.